TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Should Investors Avoid Canadian Marijuana Producers With U.S. Assets?
Investing
Cannabis Investors: Time for Concern Over Potential Regulatory Changes?
Investing
3 Reasons Marijuana Legalization Could Be Delayed
Investing
Why Aphria Inc. Could Be a Canadian Marijuana Market Leader
Investing
Is Canopy Growth Corp. a Good Investment?
Investing
Canopy Growth Corp.: Is This Stock a Long-Term Buy?
Investing
A Look at Canopy Growth Corp.’s Q1 Earnings: 2 Items That Should Concern You
Investing
Why Canopy Growth Corp. Is Down Over 1%
Investing
Will Health Risks Derail Marijuana Growth?
Investing
Why I’m Buying Aphria Inc. Over Canopy Growth Corp.